✦ LIBER ✦

The prevention and psychotherapeutic treatment of postpartum depression

✍ Scribed by S. Stuart; M. W. O’Hara; L. L. Gorman

Publisher: Springer Vienna
Year: 2003
Tongue: English
Weight: 85 KB
Volume: 6
Category: Article
ISSN: 1434-1816
DOI: 10.1007/s00737-003-0003-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Postpartum anemia II: prevention and tre

Postpartum anemia II: prevention and treatment

✍ Nils Milman 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 289 KB

Nefazodone for the treatment of postpart

Nefazodone for the treatment of postpartum depression

✍ R. Suri; V. K. Burt; L. L. Altshuler 📂 Article 📅 2005 🏛 Springer Vienna 🌐 English ⚖ 32 KB

Prevention and treatment of depression i

Prevention and treatment of depression in pregnancy and the postpartum period – summary of a maternal depression roundtable: a U.S. perspective

✍ R. C. Boyd; J. L. Pearson; M. C. Blehar 📂 Article 📅 2002 🏛 Springer Vienna 🌐 English ⚖ 41 KB

Postpartum depression: risk-factors and

Postpartum depression: risk-factors and treatments – Introduction

✍ N.M.-C. Glangeaud-Freudenthal; P. Boyce 📂 Article 📅 2003 🏛 Springer Vienna 🌐 English ⚖ 30 KB

Psychological treatment of postpartum de

Psychological treatment of postpartum depression: a meta-analysis

✍ Pim Cuijpers; Jessica G. Brännmark; Annemieke van Straten 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB

## Abstract Postpartum depression is a widespread and disruptive depressive disorder seriously affecting the lives of new mothers and their families. We conducted a meta‐analysis of controlled and comparative studies of psychological treatments of postpartum depression. Seventeen studies were inclu

New psychotherapeutic approaches to resi

New psychotherapeutic approaches to residual symptoms and relapse prevention in unipolar depression

✍ Chiara Rafanelli; Seung K. Park; Giovanni A. Fava 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

Relapse and recurrence are vexing problems of unipolar depression. Awareness of their frequent occurrence has led to the development of pharmacological long-term strategies. A substantial proportion of patients with mood disorders still display residual symptoms upon successful treatment of their il